Saturday Nov 7 | EurekAlert!
New cardiology research presented at CHEST 2009
Coronary Risk Factors Increase After Liver Transplantation Patients who have undergone a liver transplant may have a significantly increased risk for developing cardiovascular risk factors.
NeuroVive: NeuroVive doses last patient in clinical trial of...
NeuroVive Pharmaceutical AB, of Lund, Sweden, announced that on November 3, 2009 it completed the clinical phase of its study investigating tolerability and pharmacokinetics of the cremophor -free cyclosporine i.v. formula NeuroSTAT .
IJa s Bone Marrow Case: History of NOTA
Yesterday , I sketched the legal theory behind the Institute for Justice 's challenge A to the National Organ Transplant Act A of 1984 in whichA our clientsA seek to strike down the provision that makes itA a serious crime to compensate bone marrow donors.
Analytical Issues in Therapeutic Drug Monitoring
Analyzing drug concentrations has been part of the routine laboratory test menu only since the mid 1970s.
Hypoglycemia after pancreas transplantation.
Chronic hypoglycemia and the attendant decrease in quality of life have been rationales for advocating pancreas transplantation as an alternative treatment.
the Cutting Edge: Response of Keratosis Lichenoides Chronica to Efalizumab Therapy
REPORT OF A CASE A 19-year-old man presented with a 5-year history of a widespread cutaneous eruption.
Novartis International AG (CH) - Sandoz Launches First Generic Version of Prograf Capsules
Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US.
Novartis International AG (CH) - Sandoz Launches First Generic Version of Prograf Capsules
Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US.
Novartis International AG (CH) - Sandoz Launches First Generic Version of Prograf Capsules
Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US.
Sandoz launches first generic version of Prograf capsules
Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf , in the US.
OBSERVATION: Cyclosporine-Induced Infantile Nodulocystic Acne
Cyclosporine-Induced Infantile Nodulocystic Acne Jamison E. Strahan, MD ; Joanna M. Burch, MD Arch Dermatol.
this Month in Archives of Dermatology: This Month in Archives of Dermatology
You are seeing this message because your Web browser does not support basic Web standards.
Immunosuppressant Drugs: Required Labeling Changes
Sirolimus , Cyclosporine , Cyclosporine modified , Mycophenolate mofetil , Mycophenolic acid The FDA is requiring the makers of certain immunosuppressant drugs to update their labeling to reflect that immunosuppressed patients are at increased risk for opportunistic infections, such as activation of latent viral infections, including BK ...
Health Buzz: Kidney Transplant Drug Warnings and Other Health News
The Food and Drug Administration will require a new warning on the labels of drugs used by kidney transplant patients, Reuters reports .
Health Highlights: July 14, 2009
Girl's Heart Heals Itself Fewer Drunks on U.S. Roads: Survey Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Girl's Heart Heals Itself If doctors can determine how a British girl's heart healed itself, it may lead to new ways to treat cardiac patients.
BK Virus Warnings Required for Immunosuppressive Drugs
FDA announced today that the labeling for several drugs used to suppress the immune response after receipt of a kidney transplant must carry new infection warnings.
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
The FDA has said that it will require manufacturers of some immunosuppressant drugs used in kidney transplantation to update their labeling to reflect an increased risk of infections.
FDA requires label change for some transplant drugs
Novartis AG, Roche Holding AG and other makers of drugs to prevent rejection of transplanted organs will be required to note on their labels that patients are at risk for opportunistic infections when using the medicines, the U.S. Food and Drug Administration said.
Clinical Sciences: Modalities to Decrease Stromal Herpes Simplex Keratitis Reactivation Rates
John D. Sheppard, MD ; Michael L. Wertheimer, MD ; Stephen V. Scoper, MD Arch Ophthalmol.
Toxic Immune-Suppressing Drugs Could Be Replaced By Post-Transplant Combo?, Emory University Study
Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects.
Also on Topix